Brokers Issue Forecasts for Core Scientific Q1 Earnings

Core Scientific, Inc. (NASDAQ:CORZ - Free Report) - Equities researchers at Roth Capital issued their Q1 2026 earnings estimates for Core Scientific in a research report issued to clients and investors on Thursday, February 27th. Roth Capital analyst D. Aftahi forecasts that the company will earn $0.00 per share for the quarter. Roth Capital currently has a "Strong-Buy" rating on the stock. The consensus estimate for Core Scientific's current full-year earnings is $0.52 per share. Roth Capital also issued estimates for Core Scientific's Q2 2026 earnings at $0.04 EPS, Q3 2026 earnings at $0.04 EPS and Q4 2026 earnings at $0.07 EPS.

Core Scientific (NASDAQ:CORZ - Get Free Report) last issued its earnings results on Wednesday, February 26th. The company reported ($0.01) EPS for the quarter, beating analysts' consensus estimates of ($0.10) by $0.09. The firm had revenue of $94.93 million during the quarter, compared to the consensus estimate of $97.07 million.

A number of other brokerages have also commented on CORZ. Compass Point decreased their price target on shares of Core Scientific from $26.00 to $20.00 and set a "buy" rating for the company in a research note on Tuesday, February 25th. B. Riley boosted their target price on shares of Core Scientific from $16.00 to $17.00 and gave the stock a "buy" rating in a research report on Thursday, November 7th. Cantor Fitzgerald dropped their price target on shares of Core Scientific from $24.00 to $21.00 and set an "overweight" rating on the stock in a research report on Thursday, February 27th. BTIG Research boosted their price objective on Core Scientific from $19.00 to $20.00 and gave the stock a "buy" rating in a report on Monday, December 16th. Finally, Keefe, Bruyette & Woods assumed coverage on Core Scientific in a research note on Monday, January 27th. They issued an "outperform" rating and a $22.00 price objective for the company. Fifteen research analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, Core Scientific currently has an average rating of "Buy" and a consensus price target of $19.07.

Remove Ads

Core Scientific Stock Performance

Shares of NASDAQ CORZ traded down $1.51 during midday trading on Monday, hitting $8.10. 27,422,835 shares of the stock traded hands, compared to its average volume of 10,265,872. Core Scientific has a one year low of $2.61 and a one year high of $18.63. The business has a 50 day moving average price of $12.91 and a two-hundred day moving average price of $13.31. The company has a market cap of $2.38 billion, a PE ratio of -1.50 and a beta of 6.83.

Insider Activity at Core Scientific

In other news, Director Todd A. Becker sold 134,250 shares of the company's stock in a transaction dated Monday, March 3rd. The stock was sold at an average price of $10.75, for a total transaction of $1,443,187.50. Following the sale, the director now directly owns 195,687 shares in the company, valued at $2,103,635.25. This represents a 40.69 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. Also, CEO Adam Taylor Sullivan sold 88,380 shares of the firm's stock in a transaction that occurred on Thursday, January 2nd. The shares were sold at an average price of $14.24, for a total transaction of $1,258,531.20. Following the completion of the transaction, the chief executive officer now owns 4,128,505 shares of the company's stock, valued at $58,789,911.20. This trade represents a 2.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 748,282 shares of company stock worth $10,978,104. 32.00% of the stock is owned by corporate insiders.

Institutional Trading of Core Scientific

A number of hedge funds and other institutional investors have recently bought and sold shares of CORZ. Vanguard Group Inc. grew its position in Core Scientific by 54.3% during the fourth quarter. Vanguard Group Inc. now owns 19,378,652 shares of the company's stock worth $272,270,000 after buying an additional 6,819,406 shares in the last quarter. Beryl Capital Management LLC grew its holdings in shares of Core Scientific by 24.3% during the fourth quarter. Beryl Capital Management LLC now owns 18,179,586 shares of the company's stock worth $255,423,000 after purchasing an additional 3,548,396 shares in the last quarter. Driehaus Capital Management LLC increased its position in shares of Core Scientific by 112.1% in the fourth quarter. Driehaus Capital Management LLC now owns 10,264,204 shares of the company's stock worth $144,212,000 after purchasing an additional 5,424,901 shares during the last quarter. ORG Wealth Partners LLC raised its stake in Core Scientific by 0.3% in the fourth quarter. ORG Wealth Partners LLC now owns 8,986,651 shares of the company's stock valued at $126,262,000 after purchasing an additional 26,649 shares in the last quarter. Finally, FMR LLC lifted its position in Core Scientific by 2,937.7% during the fourth quarter. FMR LLC now owns 7,436,229 shares of the company's stock valued at $104,479,000 after purchasing an additional 7,191,428 shares during the last quarter.

Core Scientific Company Profile

Core Scientific, Inc provides digital asset mining services in North America. It operates through two segments, Mining and Hosting. The company offers blockchain infrastructure, software solutions, and services; and operates data center mining facilities. It also mines digital assets for its own account; and provides hosting services for other large bitcoin miners, which include deployment, monitoring, trouble shooting, optimization, and maintenance of its customers' digital asset mining equipment.